This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Ottawa directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $734,400
Use of antimicrobial peptides, LL-37/17BIPHE2, as vaginal spermicides/microbicides as part of multipurpose prevention technology (MPT)
CIHR · 2020 · Principal investigator
Use of antimicrobial peptides, LL-37/17BIPHE2, as vaginal spermicides/microbicides as part of multipurpose prevention technology (MPT)
Principal investigators: Tanphaichitr, Nongnuj; Angel, Jonathan B; Gadde, Suresh; Sheth, Prameet M
Keywords: Antimicrobial Peptide; Contraceptive; Hiv; Ll-37; Microbicide; Nanoparticle; Neisseria Gonorrhoeae; Spermicide; Vagina; Vaginal Microbiome
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.